J. Mrus

发表

Evaluating adolescents in juvenile detention facilities for urogenital chlamydial infection: costs and effectiveness of alternative interventions.

Bin Huang, F. Biro, J. Mrus, 2003, Archives of pediatrics & adolescent medicine.

Modeling the effects of spirituality/religion on patients’ perceptions of living with HIV/AIDS

Joel Tsevat, Anthony C. Leonard, Michael E. McCullough, 2006, Journal of General Internal Medicine.

Evaluation of heart murmurs in children: cost-effectiveness and practical implications.

Joel Tsevat, M. Yi, J. Mrus, 2002, The Journal of pediatrics.

Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis.

T. Heeren, J. Mrus, L. Baden, 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Insights on GRACE (Gender, Race, And Clinical Experience) from the patient's perspective: GRACE participant survey.

K. Squires, J. Currier, J. Mrus, 2013, AIDS patient care and STDs.

Comparative Cost-Efficacy Analysis of Darunavir/ritonavir and Other Ritonavir-Boosted Protease Inhibitors for First-Line Treatment of HIV-1 Infection in the United States

A. Hill, J. Mrus, A. Brogan, 2010, HIV clinical trials.

Gender differences in health-related quality of life of adolescents with cystic fibrosis

M. Yi, J. Mrus, J. Tsevat, 2006, Health and quality of life outcomes.

Cost-Effectiveness of Interventions to Reduce Vertical HIV Transmission from Pregnant Women Who Have Not Received Prenatal Care

J. Mrus, J. Tsevat, 2004, Medical decision making : an international journal of the Society for Medical Decision Making.

The cost-effectiveness of elective Cesarean delivery for HIV-infected women with detectable HIV RNA during pregnancy

M. Weinstein, S. Goldie, J. Mrus, 2000, AIDS.

Improvements in Immune Function and Activation with 48-Week Darunavir/Ritonavir-Based Therapy: GRACE Substudy

G. Hatzakis, J. Mrus, C. Tsoukas, 2013, ISRN AIDS.

The Impact of Expected HIV Transmission Rates on the Effectiveness and Cost of Ruling Out HIV Infection in Infants

M. Eckman, M. Yi, J. Mrus, 2002, Medical decision making : an international journal of the Society for Medical Decision Making.

Gender differences in health-related quality of life in patients with HIV/AIDS

Paige L. Williams, A. Wu, P. Williams, 2005, Quality of Life Research.

Patient-reported tolerability and acceptability of cabotegravir + rilpivirine long-acting injections for the treatment of HIV-1 infection: 96-week results from the randomized LATTE-2 study

M. Murray, M. Ramgopal, J. Mrus, 2019, HIV research & clinical practice.

How do patients with HIV/AIDS understand and respond to health value questions?

M. Yi, J. Mrus, J. Tsevat, 2006, Journal of General Internal Medicine.

Long-Acting Injectable Cabotegravir + Rilpivirine for HIV Maintenance Therapy: Week 48 Pooled Analysis of Phase 3 ATLAS and FLAIR Trials

S. Swindells, S. Oka, C. Orkin, 2020, Journal of acquired immune deficiency syndromes.

Getting beyond diagnostic accuracy: moving toward approaches that can be used in practice.

J. Mrus, 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Sex-Based Outcomes of Darunavir–Ritonavir Therapy A Single-Group Trial

K. Squires, J. Currier, C. Zorrilla, 2010 .

Sex-Based Outcomes of Darunavir–Ritonavir Therapy

K. Squires, J. Currier, C. Zorrilla, 2010, Annals of Internal Medicine.

Virologic Outcomes Among ART-Naïve Individuals Initiating Dolutegravir, Elvitegravir, Raltegravir or Darunavir: An Observational Study

J. Mrus, A. Oglesby, L. Brunet, 2019, Infectious Diseases and Therapy.

Biochemical and Virologic Parameters in Patients Co-Infected with Hepatitis C and HIV Versus Patients with Hepatitis C Mono-Infection

J. Mrus, J. Tsevat, A. Butt, 2007, The American journal of the medical sciences.

Beliefs of Primary Care Residents Regarding Spirituality and Religion in Clinical Encounters with Patients: A Study at a Midwestern U.S. Teaching Institution

A. Peterman, M. Yi, J. Mrus, 2005, Academic medicine : journal of the Association of American Medical Colleges.

Oral abstracts of the 21st International AIDS Conference 18–22 July 2016, Durban, South Africa

Michael I. Jordan, Donald A. Jackson, J. G. Ndirangu, 2016, Journal of the International AIDS Society.

Effects of darunavir/ritonavir-based therapy on metabolic and anthropometric parameters in women and men over 48 weeks.

J. Currier, M. Yin, J. Mrus, 2011, AIDS patient care and STDs.

Darunavir outcomes study: comparative effectiveness of virologic suppression, regimen durability, and discontinuation reasons for three-class experienced patients at 48 weeks.

Christa R. Nevin, J. Willig, M. Mugavero, 2010, AIDS research and human retroviruses.

Early virologic suppression with three-class experienced patients: 24-week effectiveness in the darunavir outcomes study

W. Klaskala, J. Willig, M. Mugavero, 2009, AIDS.

The costs of full suppression of plasma HIV RNA in highly antiretroviral-experienced patients.

A. Hill, J. Mrus, Michelle Cho, 2011, AIDS Reviews.

Efficacy and safety outcomes among treatment-experienced women and men treated with etravirine in gender, race and clinical experience.

J. Mrus, D. Jayaweera, S. Hodder, 2012, AIDS research and human retroviruses.

Pharmacokinetics and Pharmacodynamics of Darunavir and Etravirine in HIV-1–Infected, Treatment-Experienced Patients in the Gender, Race, and Clinical Experience (GRACE) Trial

J. Mrus, T. Kakuda, V. Sekar, 2012, AIDS research and treatment.

Recruitment and retention of diverse populations in antiretroviral clinical trials: practical applications from the gender, race and clinical experience study.

K. Squires, J. Currier, J. Mrus, 2011, Journal of women's health.

Darunavir, Ritonavir, and Etravirine Pharmacokinetics in the Cervicovaginal Fluid and Blood Plasma of HIV-Infected Women

J. Mrus, A. Kashuba, K. Patterson, 2010, Antimicrobial Agents and Chemotherapy.

Prior illicit drug use and missed prenatal vitamins predict nonadherence to antiretroviral therapy in pregnancy: adherence analysis A5084.

M. Chesney, S. Cohn, J. Mrus, 2008, AIDS patient care and STDs.

Risk factors predictive of anemia development during telaprevir plus peginterferon/ribavirin therapy in treatment-experienced patients.

S. Zeuzem, J. Mrus, R. Demasi, 2014, Journal of hepatology.

Religion, spirituality, and depressive symptoms in patients with HIV/AIDS

R. Hornung, A. Peterman, T. Wade, 2006, Journal of General Internal Medicine.

Spirituality and religion in patients with HIV/AIDS

A. Leonard, A. Peterman, K. Pargament, 2006, Journal of General Internal Medicine.

Utilities Derived from Visual Analog Scale Scores in Patients with HIV/AIDS

A. Wu, K. Freedberg, M. Yi, 2003, Medical decision making : an international journal of the Society for Medical Decision Making.

Total and unbound darunavir pharmacokinetics in pregnant women infected with HIV-1: results of a study of darunavir/ritonavir 600/100 mg administered twice daily

J. Mrus, P. Verboven, S. Yasin, 2013, HIV medicine.

Long-acting intramuscular cabotegravir and rilpivirine in adults with HIV-1 infection (LATTE-2): 96-week results of a randomised, open-label, phase 2b, non-inferiority trial

D. Podzamczer, B. Clotet, H. Stellbrink, 2017, The Lancet.

Long-Acting Cabotegravir and Rilpivirine for Maintenance of HIV-1 Suppression.

P. Cahn, S. Swindells, J. Mrus, 2020, The New England journal of medicine.

Do medical house officers value the health of veterans differently from the health of non-veterans?

M. Yi, J. Mrus, J. Tsevat, 2004, Health and quality of life outcomes.

Efficacy and Safety of a Single-Dose Mebendazole 500 mg Chewable, Rapidly-Disintegrating Tablet for Ascaris lumbricoides and Trichuris trichiura Infection Treatment in Pediatric Patients: A Double-Blind, Randomized, Placebo-Controlled, Phase 3 Study

P. Steinmann, I. Umulisa, J. Mrus, 2017, The American journal of tropical medicine and hygiene.

Efficacy of single-dose 500 mg mebendazole in soil-transmitted helminth infections: a review

J. Mrus, B. Baeten, M. Engelen, 2017, Journal of Helminthology.

Change in quality of life after being diagnosed with HIV: a multicenter longitudinal study.

A. Leonard, M. Szaflarski, J. Mrus, 2009, AIDS patient care and STDs.

Importance of organ dysfunction in determining hospital outcomes in children.

J. Johnston, M. Yi, J. Mrus, 2004, The Journal of pediatrics.

Spirituality and Religion in Patients with HIV/AIDS

A. Leonard, K. Pargament, A. Justice, 2009, Journal of General Internal Medicine.

Variations in Self-Rated Health Among Patients with HIV Infection

Joel Tsevat, Bruce R. Schackman, Kenneth A. Freedberg, 2006, Quality of Life Research.

Assessing darunavir/ritonavir-based therapy in a racially diverse population: 48-week outcomes from GRACE.

K. Squires, J. Currier, J. Mrus, 2012, Journal of the National Medical Association.

Sex-Based Outcomes of Darunavir–Ritonavir Therapy: The GRACE (Gender, Race, and Clinical Experience) Study

K. Squires, J. Currier, C. Zorrilla, 2010 .

A. Leonard, A. Justice, M. Yi, 2006, Journal of General Internal Medicine.

Patterns of responses on health-related quality of life questionnaires among patients with HIV/AIDS

Stacey L. Farber, A. Leonard, J. Mrus, 2006, Journal of General Internal Medicine.

Health Values of Patients Coinfected With HIV/Hepatitis C: Are Two Viruses Worse Than One?

A. Leonard, J. Mrus, J. Tsevat, 2006, Medical care.

An extracorporeal perfusion system to bridge pediatric liver transplant candidates.

R. Eberhart, J. Mrus, R. Chao, 1990, ASAIO transactions.

M. Saag, K. Squires, J. Currier, 2011, AIDS research and treatment.

Compartmentation of hexokinase in rat heart. A critical factor for tracer kinetic analysis of myocardial glucose metabolism.

H. Taegtmeyer, J. Mrus, J. 1. Mommessin, 1992, The Journal of clinical investigation.

Self-rated health of primary care house officers and its relationship to psychological and spiritual well-being

A. Peterman, M. Yi, J. Mrus, 2007, BMC medical education.

Religion, spirituality, and depressive symptoms in primary care house officers.

A. Peterman, M. Yi, J. Mrus, 2006, Ambulatory pediatrics : the official journal of the Ambulatory Pediatric Association.

The association of HIV/AIDS treatment side effects with health status, work productivity, and resource use

M. Dibonaventura, Shaloo Gupta, J. Mrus, 2012, AIDS care.

Impact of HIV/AIDS on care and outcomes of severe sepsis

J. Johnston, M. Yi, J. Mrus, 2004, Critical care.

Development of an electronic medical record-based clinical decision support tool to improve HIV symptom management.

Joel Tsevat, Joseph Erdos, Steven Farber, 2009, AIDS patient care and STDs.

Fasting and lactate unmask insulin responsiveness in the isolated working rat heart.

H. Taegtmeyer, J. Mrus, V. Nguyen, 1992, The American journal of physiology.

Pharmacoeconomics of etravirine

J. Mrus, M. Watson, J. Witek, 2010, Expert review of pharmacoeconomics & outcomes research.

Pharmacoeconomics of darunavir

J. Mrus, E. Smets, D. S. Fullerton, 2011, Expert review of pharmacoeconomics & outcomes research.

Patterns of Use and Outcomes in Patients Treated with Etravirine in the HIV Research Network

K. Gebo, J. Mrus, Cindy C Voss, 2013, AIDS research and treatment.